Stella Diagnostics, Inc.: Stella Diagnostics to Present at 23rd Annual ICR Conference
SALT LAKE CITY, UT / ACCESSWIRE / January 7, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for people living with preneoplastic and cancerous esophageal diseases, today announced that the Company s Chief Executive Officer, Dr. Joe Abdo is scheduled to present at the 23rd Annual ICR Conference to be held virtually January 11-14, 2021.
Dr. Abdo will provide a corporate update and participate in a Q&A with registered participants. The Company s presentation will begin at 1:00 PM EST on Thursday, January 14, 2021. A webcast of the presentation will be available to all registered attendees and posted under the investor relations section of the Stella Diagnostics website at StellaDX.com after the live presentation.